Podcasts about centene

In this episode, Alan Silver, President of Centene's ICHRA-focused Ambetter Health Solutions, joins the Jakob Emerson to discuss the rapid evolution of individual coverage HRAs, why large and small employers are embracing the model, and what it takes for insurers to succeed in this growing space.

In this episode, Alan Silver, President of Centene's ICHRA-focused Ambetter Health Solutions, joins the Jakob Emerson to discuss the rapid evolution of individual coverage HRAs, why large and small employers are embracing the model, and what it takes for insurers to succeed in this growing space.

China is said to consider exempting some US goods from tariffs as costs increase with Chinese authorities considering removing additional levies for medical equipment and some industrial chemicals like ethane, according to Bloomberg citing sources familiar with the matter.US President Trump said either countries negotiate a deal or they will set a deal and some will be tariffed, at some point, while they will set prices for deals.US President Trump reiterated that he hopes the Fed lowers interest rates and they should, while he reiterated criticism that the Fed is late.US equity futures slightly extended on the prior day's gains after reports of China flinching on tariffs; Alphabet shares rose 6.4% after market.European equity futures indicate a positive cash market open with Euro Stoxx 50 futures up 0.5% after the cash market closed with gains of 0.3% on Thursday.Looking ahead, highlights include UK Retail Sales, Speakers including SNB's Schlegel & Steiner, BoE's Greene, ECB's Nagel, Rehn & Cipollone, Earnings from Safran, SLB, AbbVie, Phillips 66 & Centene.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

China is said to consider exempting some US goods from tariffs as costs increase with Chinese authorities considering removing additional levies for medical equipment and some industrial chemicals like ethane, according to Bloomberg citing sources familiar with the matter.China's Foreign Ministry says it is not having any consultations or negotiations with the US on tariffs; on tariff exemptions, says not familiar with specifics.European bourses edge higher on positive Chinese trade reports; US futures mixed, GOOGL +5.5% pre-market after strong Q1 results.DXY recovers amid trade hopes, JPY weakens amid outflows from haven FX and despite hotter Tokyo CPI.Bonds trade rangebound as participants await further tariff updates.Crude modestly firmer, XAU slips given the positive risk tone and stronger USD.Looking ahead, BoE's Greene, ECB's Nagel, Rehn & Cipollone, Earnings from, SLB, AbbVie, Phillips 66 & Centene.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

On this episode of DGTL Voices, Ed interviews Bruce Lee, a seasoned technology leader with a rich background in financial services and healthcare. Bruce shares his journey from a small village in England to becoming the CTO of Centene. We discuss his passion for music, the importance of curiosity and people in technology, and his insights on bridging the gap between payers and providers in healthcare. He emphasizes the need for kindness in personal relationships and the importance of engaging with the evolving landscape of AI and technology.

In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, joins Scott Becker to break down developments in the payer world, including Centene's CEO firing amid blackmail allegations and the Medicare Advantage rate hike under new CMS Administrator Dr. Mehmet Oz.

THE TIM JONES AND CHRIS ARPS SHOW 0:00 SEG 1 Tim Jones uses the Signal app and doesn't understand how this mistaken text to a journalist could have happened 18:02 SEG 2 DAVID STOKES, Director of Municipal Policy at the Show-Me Institute | TOPIC: Election day is April 8. What will be on the ballot? | Prop B in St. Louis County | The Green Line: Will MetroLink Expansion Move Forward? | The Opera Theatre of St. Louis said Monday that it intends to buy part of the Clayton headquarters of footwear giant Caleres | The Centene Ice Center remains a financial strain on Maryland Heights https://showmeinstitute.org/author/david-stokes/https://twitter.com/DavidCStokes 33:18 SEG 3 Chris’ Corner is brought to you by https://www.elitecomfortexperts.com/ and is a headline dump https://newstalkstl.com/ FOLLOW TIM - https://twitter.com/SpeakerTimJones FOLLOW CHRIS - https://twitter.com/chris_arps 24/7 LIVESTREAM - http://bit.ly/NEWSTALKSTLSTREAMS RUMBLE - https://rumble.com/NewsTalkSTL See omnystudio.com/listener for privacy information.

THE TIM JONES AND CHRIS ARPS SHOW 0:00 SEG 1 Tim Jones uses the Signal app and doesn't understand how this mistaken text to a journalist could have happened 18:02 SEG 2 DAVID STOKES, Director of Municipal Policy at the Show-Me Institute | TOPIC: Election day is April 8. What will be on the ballot? | Prop B in St. Louis County | The Green Line: Will MetroLink Expansion Move Forward? | The Opera Theatre of St. Louis said Monday that it intends to buy part of the Clayton headquarters of footwear giant Caleres | The Centene Ice Center remains a financial strain on Maryland Heights https://showmeinstitute.org/author/david-stokes/https://twitter.com/DavidCStokes 33:18 SEG 3 Chris’ Corner is brought to you by https://www.elitecomfortexperts.com/ and is a headline dump https://newstalkstl.com/ FOLLOW TIM - https://twitter.com/SpeakerTimJones FOLLOW CHRIS - https://twitter.com/chris_arps 24/7 LIVESTREAM - http://bit.ly/NEWSTALKSTLSTREAMS RUMBLE - https://rumble.com/NewsTalkSTL See omnystudio.com/listener for privacy information.

Wednesday February 19, 2025 Centene and Health Net to Pay $11 Million to Settle False Claims Charge

(6:05am) MORNING NEWS DUMP Local officials throughout the area encourage everyone to get their cars off the street so plows can continue their removal efforts. Meanwhile, St. Louis County Executive Sam Page admits that the county is not staffed well enough to keep up with the snow plowing efforts. He says the county is short at least 40 drivers. More lawfare action for Trump today in the New York criminal case. FEMA announces aid to SoCal wildfire victims. A hockey double-header is happening tonight with proceeds benefiting the family of CBC student Colin Brown. Brown's two teams will be in action at the Centene Community Ice Center in Maryland Heights as part of the event sponsored by the Blues. The opening ceremony is at 7:45pm. Cardinals keep closer Ryan Helsley for another season. He agreed to a one-year deal for 2025. He had 49 saves last season to lead MLB. Blues (now 20-19-4) beat the Anaheim Ducks 6-2 at Enterprise Center. Up next: hosting the Columbus Blue Jackets (19-17-6)Saturday night at 6pm. (6:20am) Former NFL player Ron Freeman talks about his new book "Rethinking Race: It's Better Than What We Have Been Led To Believe." He offers a fresh look that gives cause for hope in a bright future us we embrace our founders' vision for a more perfect union. Check out the book here: https://www.amazon.com/Rethinking-Race-Better-Than-Believe/dp/B0DN88MKFT/ref=monarch_sidesheet_title (@ron_freeman) (6:35am) Financial planner Paul Curtman on Biden's Executive Orders, Trump's ideas on world conquest, and holding Republicans responsible for real action after Jan. 20. Investment and financial planning info from Paul here: https://www.prcurtman.com/ (https://www.paulcurtman.com) (@paulcurtman) (6:50am) MORNING NEWS DUMP Local officials throughout the area encourage everyone to get their cars off the street so plows can continue their removal efforts. Meanwhile, St. Louis County Executive Sam Page admits that the county is not staffed well enough to keep with the snow plowing efforts. He says the county is short at least 40 drivers. More lawfare action for Trump today in the New York criminal case. FEMA announces aid to SoCal wildfire victims. A hockey double-header is happening tonight with proceeds benefiting the family of CBC student Colin Brown. Brown's two teams will be in action at the Centene Community Ice Center in Maryland Heights as part of the event sponsored by the Blues. The opening ceremony is at 7:45pm. Cardinals keep closer Ryan Helsley for another season. He agreed to a one-year deal for 2025. He had 49 saves last season to lead MLB. Blues (now 20-19-4) beat the Anaheim Ducks 6-2 at Enterprise Center. Up next: hosting the Columbus Blue Jackets (19-17-6)Saturday night at 6pm. NewsTalkSTL website: https://newstalkstl.com/ Rumble: https://rumble.com/c/NewsTalkSTL Twitter/X: https://twitter.com/NewstalkSTL Facebook: https://www.facebook.com/NewsTalkSTL Livestream 24/7: bit.ly/NEWSTALKSTLSTREAMSSee omnystudio.com/listener for privacy information.

All the NEO Murderer updates:Luigi Mangione/Brian ThompsonMangione attended elite schoolsBA/MS PennGilman School, an elite all-boys preparatory school in Baltimore: In his valedictorian speech, Mangione praised classmates for "challenging the world"Mangione comes from a wealthy and influential Baltimore familyMangione is one of 37 grandchildren of the late Nick Mangione Sr., a prominent multimillionaire real-estate developer in Baltimore who died in 2008Members of the Mangione family own the Turf Valley Resort in Ellicott City, Maryland, and Hayfields Country Club in Hunt Valley, MarylandHe favorably reviewed the Unabomber Manifesto: Ted Kaczynski's "Industrial Society and Its Future""He was a violent individual — rightfully imprisoned — who maimed innocent people," Mangione wrote. "While these actions tend to be characterized as those of a crazy luddite, however, they are more accurately seen as those of an extreme political revolutionary.""'Violence never solved anything' is a statement uttered by cowards and predators,'" Mangione quoted.He founded an app and worked in techHe was arrested while on his laptop at a McDonald's, the police saidThe complaint said that when asked for identification, Mangione gave police officers a New Jersey driver's license with the name "Mark Rosario." When asked why he lied, Mangione replied, "I clearly shouldn't have," the complaint said.Police in Pennsylvania also found a three-page, handwritten “manifesto” taking aim at the health care industry for prioritizing profits over patient care by two law enforcement officials, according to the New York Times.Some reactionsCEO killing, rage over insurance plunges UnitedHealth into crisisBrian Thompson's death has become a symbol of revenge over denied medical bills and lack of access to necessary care, an issue that some UnitedHealth employees say they're growing increasingly anxious about.The vitriol following the shooting sparked a reckoning among some UnitedHealth employees. Much of the public animosity was aimed at the way insurance companies prevent Americans from getting the care their doctors prescribe. Some employees grappled with the idea that their paychecks were padded in part by the practice of denying care.Witty, in a video to staff last week, attempted to address the rage but failed to change the narrative for some workers. “As you've seen, people are writing things we simply don't recognize, are aggressive, inappropriate and disrespectful,” he said, urging employees to ignore the media. “There's no value in engaging.”But:Before the investor day last week was cut short, Witty used some of his time on stage to acknowledge the widespread dissatisfaction with his industry. “You only have to walk into a room with five people to hear four stories of frustration. ‘I couldn't find a doctor, I didn't know where to go. It's too difficult to understand,'” he said in a room full of financial analysts and investors.The culture at the top was shaped for years by veterans of the defunct accounting firm Arthur Andersen, where Chairman and former CEO Stephen Hemsley once worked. A previous CEO, William McGuire, unceremoniously left the company and settled with the Securities and Exchange Commission over backdating stock options that regulators alleged enriched him and other executives.In recent years, a series of acquisitions have consolidated UnitedHealth's position so much that when a cyberattack took out its Change Healthcare subsidiary, doctors offices and hospitals across the country were paralyzed. That market dominance has come under review by the Department of Justice, Bloomberg News has reported. Members of Congress who have called for a breakup of the conglomerate.Thompson was one of a handful of executives who sold UnitedHealth shares after the company learned it was under investigation by the DOJ, but before that information was shared with the public, Bloomberg reported. The company's stock fell when the DOJ investigation was reported. Thompson sold $15.1 million worth of shares, according to Bloomberg calculations.Market insanity: rage of insurer causes murder of NEO, up 1%. Social media outpour of rage over insurers because of NEO murder, down 8.5%1-star McDonald's reviews and sympathetic merch: Companies try to stop online support for CEO killer suspectTed Cruz Accuses Luigi Mangione of Being a 'Leftist' Despite Social Media Posts Praising Tucker Carlson and Decrying the 'Woke Mind Virus'After thousands celebrated UnitedHealthcare CEO Brian Thompson's killing, now even top internet sleuths are not willing to help in investigation; what's the reason?“This sparking of online praise for the killing or the killer is shocking in nature”“some are talking about Thompson being one of those responsible for the fragile state of the US Healthcare industry, which is shocking as, during other cases netizens usually post videos, condolencesFrom the Indian English-language business-focused daily newspaper: “delivering profits of a whopping $16.4 billion, in the previous year alone”How UnitedHealthcare and other insurers use AI to deny claims UnitedHealthcare and Humana have been sued over their use of algorithms to determine coverage of care for some patientsIn October, a report from the U.S. Senate Permanent Subcommittee on Investigations showed that the nation's insurers have been using AI-powered tools to deny some claims from Medicare Advantage plan subscribers.The report found that UnitedHealthcare's denial rate for post-acute care — health care needed to transition people out of hospitals and back into their homes — for people with Medicare Advantage plans rose to 22.7% in 2022, from 10.9% in 2020.The rise coincides with UnitedHealthcare's implementation of an AI model called nH Predict, originally developed by naviHealth, a subsidiary of UnitedHealth Group that has since been rebranded.Algorithms like nH Predict can analyze millions of data points to generate predictions and recommendations by comparing patients to others with apparently similar characteristics, according to an article on JAMA Network. However, the article cautions that claims of enhanced accuracy through advanced computational methods are often exaggerated.Both UnitedHealth and Humana are currently facing lawsuits over their use of nH Predict. The suits allege that insurers pressured case managers to follow the algorithm's length-of-stay recommendations, even when clinicians and families objected.One lawsuit filed last year against UnitedHealth claims that 90% of the algorithm's recommendations are reversed on appeal.The lawsuit states that UnitedHealthcare wrongfully denied elderly patients care by “overriding their treating physicians' determinations as to medically necessary care based on an AI model that Defendants know has a 90% error rate.”Leaked video shows UnitedHealth CEO defending practices that prevent ‘unnecessary' careAccording to ValuePenguin, a site that helps users compare insurance plans' costs, UnitedHealth's 32% claims denial rate was twice the industry average. Disclosure?CVS, Anthem, other big corporations remove executive photos from their websites after UnitedHealthcare CEO shootingUnitedHealthcare CEO killing spurs Centene to hold virtual meeting and insurers to pull exec photosUnitedHealthcare and other major insurance companies pull company and board leadership bios from their websites after executive's killingUnitedHealthcare and other insurers are pulling info about execs offline after a CEO was killed SecurityThis was preventable': Corporate world shudders at new risks after slaying of UnitedHealthcare CEOHere's how the killing of the UnitedHealthcare CEO will change executive security moving forwardExperts say companies will more closely track their corporate and executives' social media accounts for any potential threats.Targeted killing of UnitedHealth CEO sends a chill among executivesUnitedHealthcare CEO shooting reveals complexities in safeguarding corporate executivesThomson death benefits payout: $20,893,067100 Most Powerful People in Business Main Takeaways:Andrew Witty (51)The actual CEO at UnitedHealthThe company has been in the spotlight this year after suffering a major cyberattack, and Witty testified before Congress that data from “maybe” one-third of Americans was stolen.!28.5 POC/17.5 FMary Barra (9) was a DEI placement, Sorry, Mary.One black man? And it's a 17-year-old from a horrible restaurant. Sorry, Damola Adamolekun (89)Became CEO in August 2024; bankruptcy plan approved 10 days laterWhere's Lowe's CEO/Chair and FedEx board member Marvin Ellison?How about Eaton ($143B) CEO/Chair Craig Arnold?Also Nom chair at Medtronic ($107B) where he has 11% influenceDaniel Ek (37) way higher than Tik Tok founder and ByteDance Chair Zhang Yiming (92) from Spotifybut nobody from Snap or RedditCarlos Tavares (62)“Carlos Tavares, CEO of Stellantis, is a self-described “petrol-head” whom colleagues view as a “Samurai” laser-focused on building competitive car brands.”“on a daunting path to turn around the carmaker's fortunes before he retires in 2026. Stellantis is dealing with a bloated inventory following unpopular price hikes, with profits nearly halving in the first half of 2024 to $5.6 billion”Fired last weeK: Stellantis CEO Carlos Tavares lost control of the automaker with ‘arrogant' mistakes, sources sayDoesn't the fact that co-CEOs are listed together undermine the entire list? It means the position is powerful and not the person:Netflix: Ted Sarandos and Greg Peters (41)KKR: Scott Nuttall and Joseph Bae One of the most powerful people in business in the world doesn't even have a picture? Charlwin Mao (77): CEO and Cofounder of Chinese social media company XiaohongshuSatya Nadella (3) is more powerful than Mark Zuckerberg (7) and Jeff Bezos (11)?

Jill Wener, MD is a board-certified Internist, certified EFT/tapping practitioner and trainer, anti-racism educator, DEI consultant, trauma specialist, allyship coach, expert in physician wellness, and Co-Founder and Partner at Conscious Anti-Racism, LLC. She is also a proudly anti-Zionist Jew, and is dedicated to fighting for freedom for people of all identities. Jill is passionate about helping people take responsibility for their problems and teaching them practical, easy, rewarding, and trauma-informed tools to take self-improvement to the next level. Jill is the co-creator of the CME-accredited Conscious Anti-Racism training programs, the host of the Conscious Anti-Racism podcast, and the co-author of the best-selling Conscious Anti-Racism book. She has created CME-accredited EFT/tapping and meditation courses. Jill has worked with clients such as Georgia Aquarium, Yale University, the Accreditation Council for Graduate Medical Education, Seattle Children's Hospital, Centene, Santa Clara Medical Society, Rush University Medical Center, ChenMed, the Pittsburgh Business Group on Health, Emory University, Atkins Global, and the National Alliance for Healthcare Purchaser Coalitions. You can connect with her on Instagram and LinkedIN @jillwenerMD, as well as on her website www.jillwener.com.

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Laurin Meyer und Philipp Vetter über den Zins-Effekt der EZB an den Märkten, Renditen mit Romantik bei Netflix und den Flugtaxi-Fluch bei Lilium. Außerdem geht es um Nvidia, Micron, TSMC, Elevance Health, Centene, CVS Health, Morgan Stanley, Goldman Sachs, US Bancorp, Trump Media & Technology Group, Geo Group, CoreCivic, ExxonMobil, Chevron, Peabody Energy, Lazard, Moelis, Evercore, Bitcoin, Ethereum, Riot Platforms, Microstrategy, Coinbase, General Motors, Lithium Americas, Rio Tinto, Arcadium Lithium, Rock Tech, Vulcan Energy, Albemarle, Tesla, BYD, SPDR S&P U.S Energy Select Sector (WKN: A14QB0), Invesco Russell 2000 ETF (WKN: A0RGCT) und Global X Lithium & Battery Tech ETF (WKN: A2QPB3). Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Wilson v. Centene Mgmt

Rick Howard, N2K CyberWire's Chief Analyst and Senior Fellow, turns over hosting responsibilities to Rick Doten, the VP of Information Security at Centene and one of the original contributors to the N2K CyberWire Hash Table.  He makes the case to invigorate the automation first principle cybersecurity strategy. In this case, he is specifically addressing remediation automation. References: Staff, n.d. National Pie Championships [Website]. American Pie Council. Rick Doten. Rick's Cybersecurity Videos [Youtube Channel]. YouTube. Joe, 2020. The Unbearable Frequency of PewPew Maps [Explainer]. Stranded on Pylos. Aanchal Gupta, 2022. Celebrating 20 Years of Trustworthy Computing [Explainer]. Microsoft Security Blog. Learn more about your ad choices. Visit megaphone.fm/adchoices

Tom joins “The Opening Drive” live from Centene to talk about why his expectations for this season are to be a playoff team , why the offer sheet move for Army put a big smile on his face, keeping an eye on practices but letting his front office & staff do their job, some of the young players he's excited to watch, being interested by the amount of depth they have going into the season, what they add with an experienced coach like Claude Julien and his excitement this next season. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tom joins “The Opening Drive” live from Centene to talk about why his expectations for this season are to be a playoff team , why the offer sheet move for Army put a big smile on his face, keeping an eye on practices but letting his front office & staff do their job, some of the young players he's excited to watch, being interested by the amount of depth they have going into the season, what they add with an experienced coach like Claude Julien and his excitement this next season. Learn more about your ad choices. Visit megaphone.fm/adchoices

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. This week's commercialization news includes Dupixent's success in a chronic hives study, Lilly's development of a weekly insulin shot, and BioMarin's plans for growth. The House backs a bill restricting China's role in US biotech, while Lykos CEO is set to depart after FDA rejection and layoffs. The newsletter also discusses key developments in cell therapy and offers insights on utilizing a direct-to-patient model in the healthcare industry. Various resources and upcoming events in the biopharma industry are also highlighted. Biopharma Dive provides in-depth journalism and insights into the latest news and trends shaping the biotech and pharma industries.BridgeBio has reduced its gene therapy budget after data from a trial on an adrenal gland medicine did not meet the company's investment threshold. GlaxoSmithKline has discontinued a herpes vaccine after it did not meet efficacy goals in a phase 2 study. Roivant has launched a new 'vant' focused on a hypertension drug. Centessa's sleepiness drug has shown promising results in early studies, leading to a rise in the company's shares. Additionally, Dupixent has succeeded in a chronic hives study, giving Sanofi and Regeneron a chance to resubmit their application for approval. Investors are also paying attention to Centessa's sleepiness drug. This news comes alongside updates on other pharmaceutical developments, such as Saxenda's effectiveness for children as young as 6 and Roche's expansion of R&D labs. Additionally, the newsletter covers upcoming events and resources for biopharma professionals. Biopharma Dive provides in-depth coverage of news and trends in the biotech and pharma industries, including clinical trials, FDA approvals, gene therapy, drug pricing, and research partnerships.Iowa has awarded Centene's subsidiary, Iowa Total Care, a Medicaid managed care contract worth $2.8 billion. Telehealth groups are urging Congress and the White House to extend controlled substance virtual prescribing before pandemic-era flexibilities expire. The Biden administration has finalized a rule raising mental health coverage standards for private plans. Steward Health Care received court approval to sell its three most valuable hospitals to Orlando Health for $439 million. The importance of data quality in realizing value from medical imaging data is emphasized by Enlitic. Payers are encouraged to optimize quality and grow revenue through key strategies in an upcoming webinar. Healthcare Dive provides in-depth journalism and insight into the most impactful news and trends shaping healthcare across various sectors like health IT, policy & regulation, insurance, digital health, payer-provider partnerships, and value-based care.Novo Nordisk showcased its investigational GLP-1 pill that resulted in a remarkable 13% weight loss. This comes after positive Phase I results for the pill, which analysts compared to weight loss pills being developed by Lilly and Pfizer. Expanded coverage for cardiovascular disease under Medicare could have significant implications for Novo's obesity drug, Wegovy. Analysts estimate that the expansion of Wegovy's label beyond obesity could lead to an annual Medicare spending of $145 billion. Meanwhile, GSK has abandoned the development of its herpes vaccine after disappointing Phase I/II results, and Crispr Therapeutics and Vertex Pharmaceuticals are facing challenges in making their sickle cell gene therapy profitable. Novo's other drug, Saxenda, was found to effectively and safely lower BMI in children, according to a study published in NEJM. Additionally, Lilly continues to make progress with its once-weekly insulin, while Bain has raised $3 billion for a fund supporting life sciences companies. The biopharmaceutical industry continues to see changes, with Biomarin facing challenges and Terns moving forward in the obesity spac

Max Blau joined Megan Lynch and Tom Ackerman following his report on health care insurer Centene.  Read it  HERE

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Biopharma company ArsenalBio recently raised $325 million in funding, marking one of the largest biotech funding rounds of the year. This news comes as Biomarin focuses on growth plans centered around their drug for skeletal disorders. However, the gene and cell therapy investment market is currently experiencing a slowdown, with fewer funding rounds closed compared to previous years. On a positive note, a high-dose study of Biogen's spinal muscular atrophy drug showed promising results, while Denali Therapeutics and Regenxbio are moving forward with drug approval applications. In the oncology research sector, advancements in treatments, particularly in cancer immunotherapy and personalized medicine based on genetics, continue to be made. Despite these successes, there are reports of challenges faced by gene therapy companies, such as the closure of Astellas Gene Therapies' manufacturing facility affecting 100 employees and employers hesitant to cover the costs of rare disease treatments.The EU GMP Annex 1 revision has significant impacts on drug manufacturers, as non-compliance puts their ability to create and sell products in impacted markets at risk. Manufacturers must assess components for readiness to comply with the new regulations to avoid manufacturing non-compliance, potential product recalls, and market exclusions. To maintain compliance, staying informed about key considerations and taking steps to mitigate risks is crucial.Mississippi has awarded medicaid contracts to Centene, Molina, and TrueCare. Steward Health Care faced financial challenges with unprofitable deals in Massachusetts, while CEO Ralph de la Torre snubbed a Senate subpoena. Molina appointed its CFO to oversee its medicaid and ACA marketplace businesses. Healthcare providers are addressing burnout among staff, trends in telehealth and provider-payer relationships are being discussed. In California, the Senate passed a bill to regulate private-equity healthcare deals while a judge blocked Ohio from enforcing laws restricting medication abortions.Edwards recently laid off more than 500 employees after selling its critical care division to BD. The FDA has issued warning letters to four companies regarding ozone cleaners for CPAP machines. Abbott has partnered with Beta Bionics to integrate its glucose sensor with an automated insulin delivery system. The European Heart Group recommends renal denervation for some patients with uncontrolled high blood pressure.Biopharma Dive's newsletter on September 5, 2024, highlighted various key topics in the biopharma industry focusing on industry trends and developments. Additionally, it featured sponsored content on AI's role in life sciences and white papers on process analytical technology in the biopharma industry.The pharmaceutical industry faces challenges in reputation and communication with the media despite recent successes such as the development of COVID-19 vaccines. Merck & Co.'s Chief Communications and Public Affairs Officer is promoting openness and transparency in communication to improve the industry's reputation.Cell and gene therapy research is gaining interest from investors and innovators despite facing challenges in keeping up with industry growth. The latest developments focus on overcoming barriers with outside support and potential advancements in CAR-T cell therapy options.Payers can strategically use technology to build a solid data foundation by improving provider data quality through new technology tools.Researchers need to effectively collect social determinants of health (SDoH) data while ensuring privacy and security. A playbook provides insights on utilizing SDoH data effectively for health economics & outcomes research.Industry professionals are invited to join Snowflake Industry Day, a virtual event focusing on how technology leaders use

In this episode, Scott Becker covers seven major stories in healthcare and business, including Surgery Partners’ potential sale, HCA’s strong performance, and Tesla’s resilience. He also discusses trends in private equity, Medicaid concerns for Centene and Molina, and more.

In this episode, Scott Becker covers seven major stories in healthcare and business, including Surgery Partners’ potential sale, HCA’s strong performance, and Tesla’s resilience. He also discusses trends in private equity, Medicaid concerns for Centene and Molina, and more.

In the Medicare Advantage minute, we learn that Centene in 2025 will exit a handful of markets where they currently have MA plans. Wikipedia page on "Medicare" explains the reimbursement for Part A services. Finally, in what is looking like a year of turmoil and change, what you should expect to learn from your Annual Notice Of Change (ANOC). Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)   Inspired by: "MEDICARE FOR THE LAZY MAN 2024; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Tune in for today's industry updates.

Welcome to the only roundtable podcast in compliance as we celebrate our second century of shows. We have a plethora of topics for this episode, including the DOJ Whistleblower Incentive Program, a look at Solar Winds, a new Caremark decision, an effective internal audit and the new AI law in the EU, which we slice and dice from a variety of perspectives. We have the full quintet of Matt Kelly, Jonathan Armstrong, Karen Woody, Jonathan Marks, and our newest panelist, Karen Moore, all hosted by Tom Fox. 1. Jonathan Armstrong takes a look at the new EU Low regarding AI. He shouts out to Sir Andy Murray for a great career and life. 2. Matt Kelly asks multiple questions about the form of the guilty plea and what it may mean for compliance professionals going forward. He rants about Wyoming Senator Cynthia Lummis and her legislation for a Strategic Bitcoin Reserve. 3. Karen Moore considers the Centene case, which denied a Caremark claim. She rants about German TV only showing German competitors in their Olympic coverage and she shouts out to the perseverance of Ukrainians, where students attending class at the Kyiv School of Economics will stop class during an air raid and start class again when the All Clear is given. 4. Tom Fox shouts out to Simone Biles and the beauty, power, and grace of women's gymnastics at the Olympics, going back to Olga Korbut. 5. Karen Woody takes a deep dive into the district court's recent dismissal of the SEC complaint against SolarWinds. She shouts out to President Biden for bringing hostages home from Russia and a job well done. 6. Jonathan Marks reviews what makes internal controls effective. The members of Everything Compliance are: Karen Woody is one of the top academic experts on the SEC. Woody can be reached at kwoody@wlu.edu Matt Kelly is Founder and CEO of Radical Compliance. Kelly can be reached at mkelly@radicalcompliance.com Jonathan Armstrong is a UK colleague and an experienced data privacy/data protection lawyer in London. He can be reached at his new law firm, jonathan.armstrong@puntersouthall.law Jonathan Marks can be reached at jtmarks@gmail.com Karen Moore can be reached at kmoore51@fordham.edu The host and producer, rantor (and sometime panelist) of Everything Compliance is Tom Fox the Voice of Compliance. He can be reached at tfox@tfoxlaw.com. Everything Compliance is a part of the award-winning Compliance Podcast Network.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Rick Howard, The CSO, Chief Analyst, and Senior Fellow at N2K Cyber, discusses the current state of MITRE ATT&CK with CyberWire Hash Table guests Frank Duff, Tidal Cyber's Chief Innovation Officer, Amy Robertson, MITRE Threat Intelligence Engineer and ATT&CK Engagement lead, and Rick Doten, Centene's VP of Information Security. References: Amy L. Robertson, 2024. ATT&CK 2024 Roadmap  [Essay]. Medium. Blake E. Strom, Andy Applebaum, Doug P. Miller, Kathryn C. Nickels, Adam G. Pennington, Cody B. Thomas, 2018. MITRE ATT&CK: Design and Philosophy [Historical Paper]. MITRE. Eric Hutchins, Michael Cloppert, Rohan Amin, 2010. Intelligence-Driven Computer Network Defense Informed by Analysis of Adversary Campaigns and Intrusion Kill Chains [Historic Paper]. Lockheed Martin Corporation. Nick Selby, 2014. One Year Later: The APT1 Report [Essay]. Dark Reading. Rick Howard, 2023. Cybersecurity First Principles: A Reboot of Strategy and Tactics [Book]. Goodreads. Rick Howard, 2020. Intrusion kill chains: a first principle of cybersecurity.  [Podcast]. The CyberWire. Rick Howard, 2022. Kill chain trifecta: Lockheed Martin, ATT&CK, and Diamond. [Podcast]. The CyberWire. Rick Howard, 2020. cyber threat intelligence (CTI) (noun) [Podcast]. Word Notes: The CyberWire. Kevin Mandia, 2014. State of the Hack: One Year after the APT1 Report [RSA Conference Presentation]. YouTube. SAHIL BLOOM, 2023. The Blind Men & the Elephant [Website]. The Curiosity Chronicle. Sergio Caltagirone, Andrew Pendergast, and Christopher Betz. 05 July 2011. The Diamond Model of Intrusion Analysis. Center for Cyber Threat Intelligence and Threat Research.[Historical Paper] Staff, n.d. Home Page [Website]. Tidal Cyber. Learn more about your ad choices. Visit megaphone.fm/adchoices

Rick Howard, The CSO, Chief Analyst, and Senior Fellow at N2K Cyber, discusses the current state of “eXtended Detection and Response” (XDR) with CyberWire Hash Table guests Rick Doten, Centene's VP of Security, and Milad Aslaner, Sentinel One's XDR Product Manager. References: Alexandra Aguiar, 2023. Key Trends from the 2023 Hype Cycle for Security Operations [Gartner Hype Cycle Chart]. Noetic Cyber. Daniel Suarez, 2006. Daemon [Book]. Goodreads. Dave Crocker, 2020. Who Invented Email, Email History, How Email Was Invented [Websote]. LivingInternet. Eric Hutchins, Michael Cloppert, Rohan Amin, 2010, Intelligence-Driven Computer Network Defense Informed by Analysis of Adversary Campaigns and Intrusion Kill Chains [Paper] Lockheed Martin Corporation. Jon Ramsey, Mark Ryland, 2022. AWS co-announces release of the Open Cybersecurity Schema Framework (OCSF) project [Press Release]. Amazon Web Services. Nir Zuk, 2018. Palo Alto Networks Ignite USA '18 Keynote [Presentation]. YouTube. Raffael Marty, 2021. A Log Management History Lesson – From syslogd(8) to XDR [Youtube Video]. YouTube. Raffael Marty, 2021. A history lesson on security logging, from syslogd to XDR [Essay]. VentureBeat. Rick Howard, 2020. Daemon [Podcast]. Word Notes. Rick Howard, 2021. XDR: from the Rick the Toolman Series. [Podcast and Essay]. CSO Perspectives, The CyberWire. Rick Howard, 2023. Cybersecurity First Principles: A Reboot of Strategy and Tactics [Book]. Goodreads. Staff, n.d. Open Cybersecurity Schema Framework [Standard]. GitHub. Staff, 2019. What is EDR? Endpoint Detection & Response Defined [Explainer]. CrowdStrike. Staff, 2020. Log Formats – a (Mostly) Complete Guide [Explainer]. Graylog. Stephen Watts, 2023. Common Event Format (CEF): An Introduction [Explainer]. Splunk. Thomas Lintemuth, Peter Firstbrook, Ayelet Heyman, Craig Lawson, Jeremy D'Hoinne, 2023. Market Guide for Extended Detection and Response [Essay]. Gartner. Learn more about your ad choices. Visit megaphone.fm/adchoices

Join us for an electrifying episode of LevelUp Cyber with our special guest Niaha Dyson, CyberUp apprentice.In this episode, we dive deep into Niaha's remarkable journey, tracing her path from the United States Air Force flight lines to becoming a powerhouse cybersecurity analyst.Discover how Niaha's unique experiences and passion for problem-solving have shaped her into the cybersecurity maven she is today. From handling high-pressure situations on the flight lines to tackling complex cyber threats, Niaha's story will inspire and empower you.Tune in as we unpack invaluable insights, tips, and tricks straight from the trenches of cybersecurity. Whether you're a seasoned pro or just starting your cyber journey, this episode is a must-listen.Don't miss out! Mark your calendars and join us for an illuminating conversation with Niaha Dyson on LevelUp Cyber.#LevelUpCyber #CyberSecurity #Inspiration #Empowerment #NiahaDyson #USAF #CyberUpApprentice

In a digital world where security breaches and cyber threats loom large, the role of cybersecurity professionals is more crucial than ever. In this gripping podcast episode, we delve into the unique perspective of Otis Osborn, an Air Force veteran turned cybersecurity pro. Through his stories and experiences, listeners gain insights into the intersection of military service and the cybersecurity domain. - The parallels between military service and cybersecurity, including discipline, adaptability, and resilience. - The importance of proactive defense strategies in mitigating cyber threats. - The role of mentorship in nurturing the next generation of cybersecurity professionals. - The need for continuous learning and adaptation in the face of evolving cyber threats. Conclusion: Otis Osborn's journey from Air Force veteran to cybersecurity exemplifies the intersection of military service and technological expertise. Through his riveting anecdotes and insightful commentary, listeners gain a deeper appreciation for the vital role played by veterans in securing cyberspace and protecting critical infrastructure. This podcast serves as a tribute to all those who have served their country, both on the battlefield and in the digital realm

School vouchers are a hit...too much of one. There aren't enough to go around. CATS holds public meetings about the Red Line. Centene's defunct headquarters in University City gets new life as Vanguard buys the building and Robert F. Kennedy, Jr. says he has enough signatures to be on our state's November's ballot. Those stories and more.

Chris joins the show to break down a very successful weekend out at Centene, how the regional went for the fans and the facility, the feedback they've gotten from different groups at the event, the impression they've gotten from the NCAA on the event as they look forward to next years Frozen Four, the lessons they've learned in preparation for '25, how the home team situation was decided and his thoughts on the potential for Snuggy to join the big club this year. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Watch the full show replay on our YouTube channel! 7:00 - Cardinals take just 1 of 4 from the Dodgers -- CITY gets their first L of the season -- Blues fall 4-0 to the Sharks -- Battlehawks offense comes to a little late -- Men's & Women's Final Four madness 7:15 - Three Things we loved from the Weekend 7:30 - The Cardinals suffered another injury over the weekend--after a Spring of injuries issue--Is this a fluke, or a concern? 7:45 - TAKE IT OR LEAVE IT 8:00 – Fresh Take: The Cardinals credited Lance Lynn with energizing them in Saturday night's win. Can he be the leader the club was looking for? 8:15 - Celebrity Line - Chris Kerber 8:30 - The Fight 8:45 - Celebrity Line - Blues President Chris Zimmerman on the NCAA Hockey Tournament at Centene over the weekend, and next year's Frozen Four at Enterprise Center. 9:00 - RUSH HOUR RESET 9:15 - How disappointing was the City loss to Real Salt Lake? 9:30 - How great are the NCAA basketball tournaments? Tonight we have the drama of the rematch between Angel Reese and LSU vs. Caitlin Clark and Iowa. And then the men are headed toward a showdown between dominant UConn and dominant Purdue big man Zach Edey... 9:45 - Rocc & Roll Learn more about your ad choices. Visit megaphone.fm/adchoices

Chris joins the show to break down a very successful weekend out at Centene, how the regional went for the fans and the facility, the feedback they've gotten from different groups at the event, the impression they've gotten from the NCAA on the event as they look forward to next years Frozen Four, the lessons they've learned in preparation for '25, how the home team situation was decided and his thoughts on the potential for Snuggy to join the big club this year. Learn more about your ad choices. Visit megaphone.fm/adchoices

Watch the full show replay on our YouTube channel!7:00 - Cardinals take just 1 of 4 from the Dodgers -- CITY gets their first L of the season -- Blues fall 4-0 to the Sharks -- Battlehawks offense comes to a little late -- Men's & Women's Final Four madness7:15 - Three Things we loved from the Weekend7:30 - The Cardinals suffered another injury over the weekend--after a Spring of injuries issue--Is this a fluke, or a concern?7:45 - TAKE IT OR LEAVE IT8:00 – Fresh Take: The Cardinals credited Lance Lynn with energizing them in Saturday night's win. Can he be the leader the club was looking for?8:15 - Celebrity Line - Chris Kerber8:30 - The Fight8:45 - Celebrity Line - Blues President Chris Zimmerman on the NCAA Hockey Tournament at Centene over the weekend, and next year's Frozen Four at Enterprise Center.9:00 - RUSH HOUR RESET9:15 - How disappointing was the City loss to Real Salt Lake?9:30 - How great are the NCAA basketball tournaments? Tonight we have the drama of the rematch between Angel Reese and LSU vs. Caitlin Clark and Iowa. And then the men are headed toward a showdown between dominant UConn and dominant Purdue big man Zach Edey...9:45 - Rocc & Roll Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What's the lede on a day like today? Iggy claims it's Scheffler, but we are going to bypass that and go with Oli Marmol's extension. What's going on? John Mozeliak's comments on the move. Kelly Chase and Barrett Jackman will be in studio today at 8 am. Oli Marmol's tenure. Has our absence from the picnic table been the reason the Cardinals have struggled? Barrett Jackman and Kelly Chase join us in studio to talk about the "Puck Cancer" game being played on Friday, April 5th at Centene. Tickets are still available on Ticketmaster. Chaser and Jackman on the Blues recent run of success. Some great stories. Learn more about your ad choices. Visit megaphone.fm/adchoices

What's the lede on a day like today? Iggy claims it's Scheffler, but we are going to bypass that and go with Oli Marmol's extension. What's going on? John Mozeliak's comments on the move. Kelly Chase and Barrett Jackman will be in studio today at 8 am. Oli Marmol's tenure. Has our absence from the picnic table been the reason the Cardinals have struggled? Barrett Jackman and Kelly Chase join us in studio to talk about the "Puck Cancer" game being played on Friday, April 5th at Centene. Tickets are still available on Ticketmaster. Chaser and Jackman on the Blues recent run of success. Some great stories. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ed Herman in the studio and taking shots at all! Ed also dropping knowledge. Ed's take on Brandon Crawford. STL City SC atmosphere. Would you date an older celeb? Dolly Parton. Johnny Carson stories. Dean Martin. Being introverted. Small talk. The things that forged us. Kelly Chase comes into the studio following Ed talking about the charity game he's organizing raising money for the fight against cancer. The game will take place on Friday, April 5, at Centene. Get your tickets on Ticketmaster starting March 1. Chaser talks about the treatment he's going through. Incredible stories and perspectives from Kelly Chase. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ed Herman in the studio and taking shots at all! Ed also dropping knowledge. Ed's take on Brandon Crawford. STL City SC atmosphere. Would you date an older celeb? Dolly Parton. Johnny Carson stories. Dean Martin. Being introverted. Small talk. The things that forged us. Kelly Chase comes into the studio following Ed talking about the charity game he's organizing raising money for the fight against cancer. The game will take place on Friday, April 5, at Centene. Get your tickets on Ticketmaster starting March 1. Chaser talks about the treatment he's going through. Incredible stories and perspectives from Kelly Chase. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jacob and Nikhil sit down with Sarah London, CEO of Centene Corporation, the largest managed Medicaid organization in the country, serving 15 million Medicaid members. They discuss Medicaid partnerships and redeterminations, SDoH innovation and outcomes, and payers vertically expanding their ownership. (0:00) intro(0:39) Centene's footprint today(1:37) working with startups(6:24) Centene's priorities(12:23) how state RFPs have changed over time(15:04) differences between states(18:40) Medicaid redeterminations(22:35) will every payer end up looking like United Optum?(29:09) what kind of data is most helpful?(31:46) where Gen AI can be implemented in healthcare(35:20) ICHRA markets Out-Of-Pocket: https://www.outofpocket.health/

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.In our first news, a nurse is suing UPMC (University of Pittsburgh Medical Center) over alleged labor abuse. The lawsuit aims to represent thousands of other UPMC employees who may have been affected by the nonprofit's alleged wage suppression and other anticompetitive practices. This highlights the ongoing challenges faced by healthcare workers in the industry.Next, HSHS (Hospital Sisters Health System) is closing its operations in western Wisconsin due to financial challenges caused by the pandemic. Nonprofits in the healthcare sector have been struggling to rebound from the impact of the pandemic, leading to difficult decisions like this closure.Moving on, Bon Secours Mercy Health and a vendor are facing a lawsuit after a data breach. The suit claims that the health system and the vendor failed to implement proper security standards or promptly inform individuals whose data may have been exposed following a cyberattack. This incident serves as a reminder of the importance of robust cybersecurity measures in healthcare.In other news, Centene has named Michael Carson as the CEO of WellCare, a Medicare business. Carson, who has experience in the insurance and value-based care industry, will be leading Centene's efforts in this sector. This appointment reflects Centene's commitment to strengthening its presence in Medicare.Sanofi has announced its plans to acquire biotech company Inhibrx in a deal worth up to $2.2 billion. The acquisition will provide Sanofi with an experimental drug for alpha-1 antitrypsin deficiency, while the rest of Inhibrx's assets will be spun into a new company. This acquisition demonstrates Sanofi's strategic focus on expanding its portfolio in biotech.The FDA has ordered new cancer warnings for chimeric antigen receptor T-cell (CAR-T) therapies. The agency has requested that a black box warning for secondary T-cell malignancies be added to the labeling of all six approved CAR-T therapies. This emphasizes the importance of monitoring and addressing potential risks associated with innovative cancer therapies.Pharmaceutical companies J&J and Bristol Myers have joined a funding round for Accent Therapeutics, a startup focused on developing RNA-targeting cancer drugs. The funding round was led by Mirae Asset Capital Life Science. This investment highlights the growing interest in innovative approaches to cancer treatment.Biotech mergers and acquisitions (M&A) activity is on the rise, with Sanofi's acquisition of Inhibrx being the latest example. The industry has seen increased interest in psychiatry drug M&A, with multiple interested buyers for companies like Karuna and Cerevel. This trend reflects the evolving landscape of biotech and the pursuit of new therapeutic options.The rise of psychiatry M&A and investing in women's health are highlighted in this week's edition of Emerging Biotech Weekly. The newsletter discusses new details of proposed acquisitions in the psychiatry drug space, suggesting a potential increase in dealmaking. It also addresses the under-investment in research for women's health companies and the growing opportunities in this field.Kyverna, a biotech startup, announces plans for an initial public offering (IPO), joining other biotech companies that are testing investor appetite for new stock offerings. This demonstrates the continued interest and support for innovative biotech ventures.Mirae Asset Capital Life Science, a South Korean investment firm, launches its first US biotech fund with $50 million to support biotechnology companies. This fund provides additional resources for biotech startups to further advance their research and development efforts.In other news, gene therapy biotech Jaguar spins out a manufacturing company called Advanced Medicine Partners to offer specialized cell and gene therapy manufacturing services. T

Centene Corporation - Analyst/Investor Day

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Today we have a packed episode with news from the healthcare industry. Let's dive in.Integra is set to acquire J&J's Acclarent for $275 million, making them a market leader in ENT procedures. Illumina is divesting its acquisition, Grail, following orders from regulators. Zimvie has received clearance for its spinal fixation system through a collaboration with Brainlab. Crispr Therapeutics and Vertex Pharmaceuticals have developed a sickle cell disease therapy using Crispr technology. Heart device makers are investing in left atrial appendage closure as a potential $6 billion market by 2030. Activist investor Engaged Capital has taken a stake in Nevro.Pfizer is planning to deepen its cost cuts after sales forecasts missed expectations. Vertex Pharmaceuticals is building a case for a non-opioid pain drug. Doctors at the ASH meeting have praised new sickle cell gene therapies. Biotech mergers and acquisitions are picking back up, with Astrazeneca's acquisition of Icosavax being the first large buyout of a vaccine developer since GSK's purchase of Affinivax. Tome Biosciences has debuted with $213 million in funding.Centene attempted to ease concerns about the potential overhaul of the ACA. KKR is reportedly in talks to buy a stake in Cotiviti. Google has revealed new generative AI models for healthcare called MedLM. Cerner is expected to be a growth story for Oracle after this fiscal year. There have been reports of hackers having access to patient information in a cyberattack on a New York hospital.Pfizer's stock price dropped after providing its full-year 2024 guidance. Johnson & Johnson and Genmab released data from a phase III study of their darzalex faspro-based quadruplet therapy. The FDA has created the Genetic Metabolic Diseases Advisory Committee. Biopharma companies are shifting their advertising budgets away from Xplus. South Africa is moving towards greater local biopharmaceutical production.AstraZeneca is set to acquire vaccine maker Icosavax. The FTC has led Sanofi to terminate a drug research deal with Maze Therapeutics. Editas presented its gene therapy for sickle cell disease at the ASH23 conference. Tome Biosciences has debuted with $213 million in funding. Bristol Myers Squibb has paid SystImmune $800 million in a deal involving ADCs. AbbVie's Humira leads ICER's list of "unsupported" price hikes. Pfizer presented new data at the ASH conference.Bristol Myers Squibb has acquired the rights to develop SystImmune's bi-specific ADC. Pfizer's acquisition of Seagen has cleared regulatory hurdles. Sanofi has dropped its acquisition of Maze Therapeutics' Pompe disease drug. AstraZeneca has entered the RSV vaccine market with its purchase of Icosavax. Sino Biological has developed three HEK293 expression-based platforms.The Daily Dive newsletter from Marketing Dive highlights several key stories. Oscar Mayer and Mint Mobile are teaming up for a national campaign called "A Side of Bacon." Frito-Lay is reaffirming its commitment to diverse creators with a new campaign called "My Joy." IPG Mediabrands has struck a deal with Amazon for ad-supported streaming. The newsletter also includes an opinion piece on retail media networks and an upcoming virtual event on generative AI in marketing.The pharmaceutical industry is preparing for upcoming changes and challenges. The cost of medicine is expected to be a major debate point in the 2024 presidential election. Bristol Myers Squibb's Chief Commercial Officer discusses the industry's shifting approach. The article includes sponsored content from AstraZeneca, highlighting their expansion in blood cancer care. The text concludes with links to other resources and press releases.And that's all for today's episode. Stay tuned for more important news from the Pharma and Biotech world. Goodbye!

Centene Corporation, Q3 2023 Earnings Call, Oct 24, 2023

Tom talks with Cardinals fan Lydia Olmsted about her catching a foul ball. Cardinals Manager Oli Marmol joins the show talking about the young players learning a lot and Wainwright playing his final game. KMOX Golf Analyst Dan Reardon joins the show talking about the Ryder Cup and the struggle by the Americans. Blues CEO Chris Zimmerman talking about the push to host the 2026 World Junior Championships and Centene.

An unscheduled update on covid vaccinations and a major GP provider leaving UK.

US equity futures are indicating a broadly flat open as of 05:00 ET. This follows a mostly positive session in Asia, while European equity markets are higher in early trading. Sentiment remains positive after Tuesday's US data supported expectations of a Fed pause and fits in with the soft landing narrative. Other supportive factors include reduced volatility, China stimulus and recent M&A pickup, along with favorable positioning dynamics.Companies Mentioned: Amazon, Centene

In this episode of “Inside Health Care,” we talk digital transformation with a prominent medical informaticist. Then, we hear a conversation on NCQA's long-term services and supports programs, a.k.a. LTSS, from a long-time accredited managed care supporter.Dr. John Glaser is Executive in Residence at Harvard Medical School Executive Education. Previously he was Chief Executive Officer of Siemens Health Services. He is former Chair of the Global Agenda Council on Digital Health in the World Economic Forum, and former Senior Advisor to the Office of the National Coordinator for Health Information Technology. He's also a member of NCQA's Board of Directors.Dr. Glaser will also be at NCQA's second annual Health Innovation Summit in October 2023. In addition to helping open the Summit, he'll sit on a C-suite panel alongside NCQA President Peggy O'Kane and other industry leaders, discussing, among other things, the transition to a digital health ecosystem.Centene is the largest Medicaid Managed Care Organization in the U.S., as well as the largest carrier on the Health Insurance Marketplace.Nicole McLean is an accreditation manager for Centene, and she spends much of her time working with NCQA on our LTSS programs. But which services are included in LTSS? What could they be? Well, as Nicole will tell you, in order to evaluate which services and supports people need, you first have to learn about...the patient.Later in our Fast Facts segment, we observe August as National Immunization Awareness Month. First, we present some tips from the CDC for providers' offices on how to talk about vaccinations to young patients and their families. We also mention NCQA's HEDIS "Childhood Immunization Status" measure.

Rick Howard, The CSO, Chief Analyst, and Senior Fellow at N2K Cyber, discusses the current state of Distributed Denial of Service (DDOS) prevention with CyberWire Hash Table guests Steve Winterfeld, Akamai's Field CSO, and Jim Gilbert, Akamai's Director Product Management, and Rick Doten, the CISO for Healthcare Enterprises and Centene. Howard, R., 2023. Cybersecurity First Principles: A Reboot of Strategy and Tactics [Book]. Wiley. URL: https://www.amazon.com/Cybersecurity-First-Principles-Strategy-Tactics/dp/1394173083.   Azure Network Security Team, 2023. 2022 in review: DDoS attack trends and insights [Website]. Microsoft Security Blog. URL https://www.microsoft.com/en-us/security/blog/2023/02/21/2022-in-review-ddos-attack-trends-and-insights/ Howard, R., 2014. Fatal System Error [Book Review]. Cybersecurity Canon Project. URL https://icdt.osu.edu/fatal-system-error Mashable, 2019. The World's First Cyber Crime: The Morris Worm [KERNEL PANIC] [Video]. YouTube. URL https://www.youtube.com/watch?v=o2dj2gnxjtU (accessed 8.8.23). Montgomery, D., Sriram, K., Santay, D.J., 2022. Advanced DDoS Mitigation Techniques [Website]. NIST. URL https://www.nist.gov/programs-projects/advanced-ddos-mitigation-techniques. Schomp, K., Bhardwaj, O., Kurdoglu, E., Muhaimen, M., Sitaraman, R.K., 2020. Akamai DNS: Providing Authoritative Answers to theWorld's Queries [Conference Paper]. Proceedings of the Annual conference of the ACM Special Interest Group on Data Communication on the applications, technologies, architectures, and protocols for computer communication. URL https://groups.cs.umass.edu/ramesh/wp-content/uploads/sites/3/2020/07/sigcomm2020-final289.pdf Sparling, C., Gebhardt, M., 2022. The Relentless Evolution of DDoS Attacks [Blog]. Akamai Technologies. URL https://www.akamai.com/blog/security/relentless-evolution-of-ddos-attacks. Staff, January 2023. The Evolution of DDoS: Return of the Hacktivist [Akamai White Paper]. FS-ISAC. URL https://www.fsisac.com/akamai-ddos-report. Staff , 2023. 2023 The Edge Ecosystem [White Paper]. AT&T Cybersecurity. URL https://cybersecurity.att.com/resource-center/infographics/2023-securing-the-edge. Winterfeld, S., 2023. Ransomware on the Move: Evolving Exploitation Techniques and the Active Pursuit of Zero-Days [Website]. Akamai Technologies. URL https://www.akamai.com/blog/security/ransomware-on-the-move-evolving-exploitation-techniques Radware, 2012. DNS Amplification Attack [Video. YouTube. URL https://www.youtube.com/watch?v=xTKjHWkDwP0  Chickowski, E., 2020. Types of DDoS attacks explained [Website]. AT&T Cybersecurity. URL https://cybersecurity.att.com/blogs/security-essentials/types-of-ddos-attacks-explained Nilsson, J., 2010. The Book of Numbers: A History of the Telephone Book [Website]. The Saturday Evening Post. URL https://www.saturdayeveningpost.com/2010/02/book-numbers

Stephanie Tilenius successfully led her first startup through an IPO. Now she is taking on the healthcare space, which makes up 20% of GDP in the United States. Her latest venture, Vida Health, has attracted funding from top-tier investors like Centene, Lumir Ventures, Hamilton Lane, and Canvas Ventures.

Between the emergence of sophisticated nation-state actors, the rise of ransomware-as-a-service, the increasing attack surface remote work presents, and much more, organizations today contend with more complex risk than ever. A “Secure-by-Design” approach can secure software environments, development processes and products. That approach includes increasing training for employees, adopting zero trust, leveraging Red Teams, and creating a unique triple-build software development process. SolarWinds calls its version of this process the "Next-Generation Build System," and offers it as a model for secure software development that will make supply chain attacks more difficult. On this episode of CyberWire-X, host Rick Howard, N2K's CSO, and CyberWire's Chief Analyst and Senior Fellow, discusses software supply chain lessons learned from the SolarWinds attack of 2020 with Hash Table members Rick Doten, the CISO for Healthcare Enterprises and Centene, Steve Winterfeld, Akamai's Advisory CISO, and Dawn Cappelli, Director of OT-CERT at Dragos, and in the second half of the show, Rick speaks with our episode sponsor, SolarWinds, CISO Tim Brown.